|Home | About | Journals | Submit | Contact Us | Français|
This paper is Open Access. Copying, printing, redistribution and storage permitted. Journal © 1997-2008 Biological Procedures Online
The early chick embryo contains subpopulations of cells that express lineage-specific transcription factors. We have developed protocols to examine the role of these cells during development that involve labeling them for cell tracking purposes and ablating them within the epiblast. The procedures take advantage of the fact that subpopulations of epiblast cells differentially express cell surface antigens recognized by monoclonal antibodies. Embryos are removed from the shell and incubated on the yolk with an antibody. Cells that bind the antibody are either tagged with a fluorescent secondary antibody or lysed with complement. For long-term analyses, embryos are returned to a host shell and placed in an incubator. This method of whole embryo manipulation ex-ovo and incubation in-ovo supports normal development into the fetal period.
The epiblast of the chick embryo contains small numbers of cells that contain mRNAs for the basic helix-loop-helix transcription factors MyoD and NeuroM that are markers for the skeletal muscle and neuronal lineages, respectively (1-6). All MyoD positive epiblast cells synthesize a cell surface antigen recognized by the G8 monoclonal antibody (MAb) (3-6). The E12 MAb binds to a cell surface antigen present on a subpopulation of NeuroM expressing cells (4). In order to examine the roles of MyoD- and NeuroM-positive epiblast cells in embryonic tissues, we have developed protocols to label and ablate these subpopulations in living embryos prior to the onset of gastrulation. Fluorescent secondary antibodies were used to visualize G8 and E12 labeled cells. Lysis of antibody labeled cells was carried out by incubating embryos in complement. A critical component of these experiments was the development of a method that would support the growth of embryos manipulated at the blastula stage into the fetal period.
An ex-ovo whole embryo culture system was developed over 50 years ago to facilitate experimentation with the early chick embryo (7). The method involves removing the embryo from the yolk and culturing it on a glass ring in albumen. Several modifications have been made to the New culture method, including replacing the medium with a mixture of thin albumen and Bactoagar (8) and placing the embryos on a nucleopore or filter paper raft (9,10). The Early Chick Method of Chapman et al. (10) permits the establishment of more cultures in less time and supports the development of younger embryos compared to the New culture system. The visibility and accessibility of the embryo in these ex-ovo culture systems facilitates tissue manipulations (11). However, the limitation of these culture systems is that development progresses normally for only 72 hours (10).
Longer term evaluation of chick embryo development can be carried out by the “shell-less method” originally developed in the laboratory of Dr. Judah Folkman (12). This method involves culturing embryos on the yolk in petri dishes. Modifications to the original procedure include suspending embryos on a tripod in plastic wrap (13), or growing them in plastic cups (14,15) or hexagonal polycarbonate weigh boats (16,17). Survival is low if cultures are established with embryos younger than 38 hours of incubation (Jean-Marie Gasc, personal communication). Addition of eggshell as a source of calcium to shell-less cultures increases the survival of 48 hour embryos beyond day 14 (18-21).
Chick embryos can also be cultured in surrogate eggshells (22-25). The original procedure was a three step process in which fertilized ova recovered from the oviduct were cultured in a glass jar for 24 hours, transferred to a windowed host shell for three days and transferred again to a second larger shell through hatching (22). Under these conditions the maximum rate of hatching was 23%. Hatching increased to 63% when the process began with the second step using blastoderm stage embryos.
Embryos can be manipulated directly in the shell. In this procedure, a window is cut in the shell and the embryo on the yolk is stabilized for manipulation by removing some of the albumen (26). As with the shell-less culture methods, survival rates increase when these in–ovo cultures are established after 36 hours of development (Dr. Matthew Korn, personal communication).
Our procedure is a hybrid of the shell-less and in-ovo culture methods. The procedure involves placing the contents of the egg into a tissue culture dish, labeling or ablating cells in the embryo while it resides on the yolk and transferring the embryo to a single host shell for growth into the fetal period. Our technique for labeling or ablating cells with complement depends on the existence of antibodies that specifically recognize surface antigens differentially expressed on subpopulations of cells. The advantages of this method are the ability to precisely target specific cell types in the blastula and the high rate of survival of manipulated embryos into the fetal period.
The contents of the egg were gently emptied into a Petri dish. Embryos residing on the yolk were staged according to the method of Hamburger and Hamilton (27). Stages 2 and 4 embryos were incubated in 100 µl of the G8 or E12 MAb diluted 1:20 in Dulbecco’s phosphate buffered saline (PBS) (Invitrogen) for 45 minutes at room temperature and rinsed three times with PBS. The G8 and E12 IgM MAbs bind to uncharacterized antigens present on the surface of cells expressing MyoD or NeuroM mRNA, respectively (3-6). Control embryos were incubated in PBS lacking primary antibody. For cell tracking experiments, rinsing was followed by incubation at room temperature for 45 minutes in goat anti-mouse IgM conjugated with rhodamine (Chemicon) diluted 1:600 in PBS. Embryos were rinsed three times in PBS. Diffusion of primary and secondary antibodies was limited by overlying the solutions with a piece of parafilm as described in the Protocols section.
Cell ablation within the stage 2 epiblast was carried out by incubating cells with the G8 or E12 MAb as described above, rinsing in PBS and applying 100 µl of baby rabbit complement (Cedar Lane, Inc.) diluted 1:40 in ice cold, sterile Hanks' buffered saline containing 0.1% bovine serum albumen. Embryos were incubated in complement for 30 minutes at room temperature. Control embryos were incubated in Hanks’ buffer solution instead of primary antibody and then treated with complement. Dead cells were visualized by incubating embryos in 0.2% trypan blue (Sigma Aldrich) in PBS for 15 minutes. Embryos that were not incubated in trypan blue were transferred to host shells as described below.
Host shells were prepared under sterile conditions by cutting a window in the egg and removing its contents. Embryos that were labeled with antibodies or treated with complement on the yolk were poured into the host shell. The thick albumen was poured into the shell first, followed by the embryo on the yolk. Thin albumen was used to fill the shell until the embryo was approximately 0.5-1 cm below the opening. The window was covered with a sterile piece of plastic wrap. Treated and control embryos were incubated at 37oC for a maximum of 17 days.
Embryos were fixed overnight in 4% formaldehyde. Whole stage 2 and 14 embryos and transverse 10 µm paraffin sections of 5 and 6 day embryos were counterstained with Hoechst nuclear dye (Sigma Aldrich) and mounted in Elvanol (Dupont). Fluorescent cells were visualized with a Nikon Eclipse 800 epifluorescence microscope (Optical Apparatus) equipped with a 530-560 nm excitation and 573-648 nm barrier filters for rhodamine and 330-380 nm excitation and 435-485 nm barrier filters for Hoechst dye. Some sections were stained with hematoxylin and eosin Y (Richard Allen Scientific). Photographs were taken under 4x NA 0.2 and 60x oil NA 1.4 objectives. Images were produced with the Evolution QE Optronics video camera (Media Cybernetics) and the Image Pro Plus image analysis software program (Phase 3 Imaging Systems). Figures were annotated and adjusted for brightness and contrast using Adobe Photoshop 6.0.
Our ex-ovo/in-ovo procedure is a precise and efficient method for labeling and ablating cells in blastula stage chick embryos that supports development into the fetal period. We have used this procedure to fluorescently label subpopulations of epiblast cells that express myogenic and neurogenic transcription factors with the G8 and E12 MAbs, respectively (4-6). In the stage 2 embryo, the G8 and E12 MAbs bind to separate populations of cells in the posterior epiblast (Fig. 1A and B) (4). A second and larger subpopulation of E12-positive cells is present in the anterior epiblast (4,5).
Embryos were incubated in host shells in order to analyze the sites of incorporation of G8 and E12 labeled epiblast cells as development progressed. Approximately 75% of embryos were visible through the window in the shell for the first three days after transfer (Fig. 1C). All embryos became visible through the window by the fourth day in-ovo, thereby permitting daily observations of morphogenesis. The survival rate of embryos labeled with antibodies during stages 1-4 and returned to host shells and J). E12-positive cells were observable in whole embryos for an additional 48 hours of development by epifluorescence microscopy, although confocal microscopy or sectioning the embryos is required for quantitative analyses. These experiments demonstrate that epiblast cells can be labeled with non-function perturbing antibodies ex-ovo and cultured in host shells without adversely affecting development. Detection of antigens sensitive to endogenous protease digestion may require incubations at 4oC instead of room temperature.
The technique of complement-induced cell lysis was utilized over 50 years ago to examine antigenicity in the chick embryo (28). We have taken advantage of complement’s ability to lyse cells bound with antibodies to eliminate specific subpopulations within the epiblast that express different cell surface antigens (5). Incubation in baby rabbit complement alone at a dilution of 1:40 did not increase cell death in the epiblast (Fig. 2A). Labeling cells with the G8 and E12 MAbs followed by incubation in complement resulted in lysis of separate populations of epiblast cells, as determined by the uptake of trypan blue (Fig. 2B and C) (5). Testing the specificity of lysis of antibody labeled cells with different concentrations of complement purified from various sources is recommended for each primary antibody and stage of development.
Lysis of subpopulations of epiblast cells labeled with the G8 or E12 MAbs produced different malformations as development progressed. Elimination of G8-positive cells in the stage 2 epiblast led to a herniation of organs through the ventral body wall (Fig. 2E and H). Loss of integrity of the body wall resulted from a dramatic reduction in skeletal muscle in the myotome (5). The mechanism whereby G8/MyoD-positive epiblast cells regulate myogenesis in the somites involves the production of the bone morphogenetic inhibitor Noggin (5). These embryos died between the sixth and seventh day of development.
Lysis of the subpopulation of NeuroM expressing cells recognized by the E12 MAb led to neural tube defects (Fig. 2I). The role of E12-positive epiblast cells during neural tube development has not yet been characterized. Embryos treated with E12 and complement remained viable for at least nine days. Exposure to baby rabbit complement alone did not produce malformations in the embryo (Fig. 2D and G).
We have used this ex-ovo/in-ovo procedure to follow the fate of cells labeled in the epiblast and to determine the effects of ablating them on differentiation and morphogenesis (5,6). Our procedure requires no special equipment other than a dissecting microscope and a fiber optic light source for illumination from above. A significant advantage of this ex-ovo/in-ovo procedure over previously published culture methods, including the technique of manipulating embryos through a window in the shell, is that experiments can be initiated prior to the onset of gastrulation and subsequently grown to fetal stages with a high rate of survival. The application of antibodies for labeling or ablation is achieved without perturbing the embryo.
The procedures we have developed for cell tracking and ablation depend on the existence of antibodies that recognize cell surface antigens expressed on specific subpopulations in the early embryo. Other methods of marking cells that could be used with our ex-ovo/in-ovo system include transplantation of quail cells into chick hosts (29), microinjection of vital dyes (30-33) and microinjection or electroporation of genes coding for fluorescent proteins (34,35). Microinjection of fluorescent dyes followed by laser ablation was used to eliminate cells in stages 12-18 embryos grown in shell-less cultures (17). This approach could be attempted with blastula stage embryos using the ex-ovo/in-ovo protocol.
An important advantage of our ex-ovo/in-ovo method is that it supports the development of embryos manipulated at the blastula stage into the fetal period. The success of this method may be attributed, in part, to returning the embryo to the shell that maintains the appropriate tension on the yolk and provides calcium to the embryo. Although we have not yet extended our experiments beyond day 17, the host shell is expected to support development until hatching.
We thank Dr. Karen Knudsen and Justin Elder for critically reading the manuscript. This work was supported by NIH HD043157 and AR52326 (MGW).